Get the Stockscreener App
1.08
2.86%
0.03
After Hours:
1.09
0.01
+0.93%
Therapeuticsmd Inc stock is traded at $1.08, with a volume of 29,997.
It is up +2.86% in the last 24 hours and up +0.00% over the past month.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
See More
Previous Close:
$1.05
Open:
$1.06
24h Volume:
29,997
Relative Volume:
1.62
Market Cap:
$12.50M
Revenue:
$996.00K
Net Income/Loss:
$-6.09M
P/E Ratio:
-2.0377
EPS:
-0.53
Net Cash Flow:
$-9.76M
1W Performance:
+0.47%
1M Performance:
+0.00%
6M Performance:
+19.47%
1Y Performance:
-34.94%
1-Day Range:
$1.05
$1.0854
1-Week Range:
$0.99
$1.1335
52-Week Range:
$0.70
$2.44
Therapeuticsmd Inc Stock (TXMD) Company Profile
Name
Therapeuticsmd Inc
Sector
Phone
561-961-1900
Address
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Compare TXMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
1.08 | 12.41M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
142.77 | 64.42B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.46 | 45.95B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
8.82 | 39.14B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.07 | 22.90B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
456.84 | 20.50B | 3.08B | 1.24B | 1.07B | 25.61 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-20 | Downgrade | Jefferies | Hold → Underperform |
| May-19-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-02-19 | Initiated | Guggenheim | Buy |
| Oct-17-19 | Initiated | H.C. Wainwright | Buy |
| Apr-30-19 | Resumed | Noble Capital Markets | Outperform |
| Jun-15-18 | Initiated | JP Morgan | Overweight |
| Sep-08-17 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-11-17 | Upgrade | Oppenheimer | Perform → Outperform |
| May-09-17 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-22-16 | Resumed | Jefferies | Buy |
| Nov-22-16 | Initiated | Oppenheimer | Outperform |
| Nov-07-16 | Resumed | Guggenheim | Buy |
| Apr-04-16 | Initiated | Goldman | Buy |
| Dec-08-15 | Reiterated | Jefferies | Buy |
| Dec-08-15 | Reiterated | Stifel | Buy |
| Sep-21-15 | Reiterated | Jefferies | Buy |
| Jun-09-15 | Initiated | Guggenheim | Buy |
| Jul-08-14 | Initiated | FBR Capital | Outperform |
| Apr-17-14 | Reiterated | Noble Financial | Buy |
| Jan-28-14 | Reiterated | Noble Financial | Buy |
View All
Therapeuticsmd Inc Stock (TXMD) Latest News
What analysts say about TherapeuticsMD Inc stockTrendline Breakouts & Minimal Capital Investment - earlytimes.in
Is TherapeuticsMD Inc. (29TA) stock a good hedge against inflationExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-10-05 04:45:14 - newser.com
How TherapeuticsMD Inc. (29TA) stock reacts to weak economy2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Forecasting TherapeuticsMD Inc. price range with options dataWeekly Stock Recap & High Yield Equity Trading Tips - newser.com
Is TherapeuticsMD Inc. stock attractive for hedge fundsWeekly Profit Report & Detailed Earnings Play Strategies - newser.com
Can TherapeuticsMD Inc. (29TA) stock ride next bull market cycleProduct Launch & High Return Trade Opportunity Guides - newser.com
Real time pattern detection on TherapeuticsMD Inc. stockFed Meeting & Real-Time Volume Analysis Alerts - newser.com
TherapeuticsMD Inc 29TA Stock Analysis and ForecastBearish Engulfing Patterns & Small Investment Growth Plans - earlytimes.in
TherapeuticsMD Inc Stock Analysis and ForecastTrade Execution Strategies & Rapid Capital Appreciation - earlytimes.in
What analysts say about TherapeuticsMD Inc 29TA stockMarket Volatility Update & Interactive Charts for Smarter Trading - earlytimes.in
What drives TherapeuticsMD Inc stock priceRisk Adjusted Returns & Small Budget Wealth Building - earlytimes.in
Is TherapeuticsMD Inc a good long term investmentDividend Yield Trends & Free Expert Guidance For Growth - Early Times
Intraday pattern recognizer results for TherapeuticsMD Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - newser.com
TherapeuticsMD Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Can TherapeuticsMD Inc. rally from current levelsWeekly Trade Summary & Community Consensus Picks - newser.com
Analyzing net buyer seller activity in TherapeuticsMD Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - newser.com
How to recover losses in TherapeuticsMD Inc. stock2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com
TherapeuticsMD Inc. stock trendline breakdownProfit Target & Advanced Swing Trade Entry Alerts - newser.com
Is TherapeuticsMD Inc. still worth holding after the dipPrice Action & Precise Entry and Exit Recommendations - newser.com
Can technical indicators confirm TherapeuticsMD Inc.’s reversalPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Real time breakdown of TherapeuticsMD Inc. stock performancePortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Will TherapeuticsMD Inc. benefit from macro trendsPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Patterns Watch: Will TherapeuticsMD Inc outperform small cap indexes2025 Winners & Losers & High Accuracy Investment Signals - khodrobank.com
Price momentum metrics for TherapeuticsMD Inc. explainedWeekly Risk Report & Entry and Exit Point Strategies - newser.com
Therapeuticsmd Inc Stock (TXMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):